Please login to the form below

Not currently logged in
Email:
Password:

Chris Viehbacher

This page shows the latest Chris Viehbacher news and features for those working in and with pharma, biotech and healthcare.

Former Sanofi CEO Viehbacher takes health investment role

Former Sanofi CEO Viehbacher takes health investment role

Chris Viehbacher has added another job to his portfolio of roles since being ousted as Sanofi's chief executive last year. ... Chris has these qualities in abundance.”. Viehbacher (pictured above) takes over at Gurnet Point Capital from Fereydoun

Latest news

  • Sanofi's CEO search ends as Bayer's Brandicourt takes the job Sanofi's CEO search ends as Bayer's Brandicourt takes the job

    But also of note is Brandicourt's French nationality, which could help avoid some of the culture clashes said to have blighted former CEO  Chris Viehbacher's tenure at Sanofi. ... As Viehbacher's replacement Brandicourt faces a number of challenges,

  • Rumour mill intensifies around Bayer’s Brandicourt for Sanofi Rumour mill intensifies around Bayer’s Brandicourt for Sanofi

    Sanofi Chairman Serge Weinberg vowed recently that the successor to former CEO Chris Viehbacher - who was fired last October after clashes with the company's board of directors - would be named ... Brandicourt has been linked to the job a number of times

  • Genzyme cuts staff and signs $845m gene therapy pact Genzyme cuts staff and signs $845m gene therapy pact

    The announcements come as Sanofi is still searching for a replacement for former chief executive Chris Viehbacher, who was fired last October after clashes with the company's board of directors.

  • Leaderless Sanofi sees strong growth Leaderless Sanofi sees strong growth

    Sanofi has been boosted by a healthy growth in revenue for 2014 but its chairman remains under pressure to find a new chief executive after last year's ousting of Chris ... Last year its long-standing CEO Viehbacher was voted out by the firm's board,

  • Genzyme's oral Gaucher drug cleared in Europe Genzyme's oral Gaucher drug cleared in Europe

    Sanofi ex-chief executive Chris Viehbacher said recently that he did not expect Cerdelga to completely cannibalise Cerezyme sales, as the oral drug does not have an indication for use in

More from news
Approximately 2 fully matching, plus 44 partially matching documents found.

Latest Intelligence

  • Creating stability with medicines framework Creating stability with medicines framework

    The framework agreement was developed on the basis of a conversation between then EFPIA president, Chris Viehbacher, and the Prime Minister of Lithuania, within the context of the Lithuanian Presidency of

  • Going the distance Going the distance

    This comes after its former CEO, Chris Viehbacher, last year conceded the company had been rather 'light' on launches.

  • Pharma deals during October 2014 Pharma deals during October 2014

    So watch this space. The need to keep the shareholders happy is paramount as evidenced by the rather unexpected dispatch of Sanofi's CEO Chris Viehbacher following concerns over the impact

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    Chris Viehbacher has said too that he was very happy that Genzyme actually influenced Sanofi's culture in that respect.”. ... It also followed a series of changes at the company following Viehbacher's 2008 appointment as chief executive, such as the

  • Pharma deals during November 2013 Pharma deals during November 2013

    This trend was reinforced by comments made by Sanofi's CEO Chris Viehbacher, who has stated the company's intention to spend between $1.4bn and $2.7bn per annum on

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    For example, the recently departed CEO of Sanofi, Chris Viehbacher, remarked in 2012, “ Places like Colombia have become extremely interesting in terms of growth”.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics